Novartis Ag ADR (NY: NVS )
107.42
+2.20
(+2.09%)
Streaming Delayed Price
Updated: 2:50 PM EDT, Jun 24, 2024
Add to My Watchlist
All News about Novartis Ag ADR![]() ![]() ![]()
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Via Benzinga
![]()
How Is The Market Feeling About Novartis?
November 10, 2023
Via Benzinga
![]() ![]() ![]()
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
November 01, 2023
![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|